Management of Psoriasis: (Volume-38 Current Problems in Dermatology)

Management of Psoriasis is a comprehensive and clinically focused volume in the esteemed series Current Problems in Dermatology, dedicated to the modern understanding and treatment of psoriasis. This text provides an in-depth review of pathogenesis, clinical presentation, and evolving therapeutic strategies, making it an essential reference for dermatologists, clinicians, and researchers involved in psoriasis care.

Psoriasis is a chronic, immune-mediated inflammatory skin disorder affecting approximately 2–3% of the global population. The book begins by outlining the epidemiology and genetic basis of psoriasis, emphasizing the strong hereditary component and the identification of susceptibility loci such as PSORS1. Environmental triggers—including infections, stress, medications, trauma (Koebner phenomenon), and lifestyle factors—are discussed as contributors to disease onset and exacerbations. The systemic nature of psoriasis is highlighted, particularly its association with psoriatic arthritis, metabolic syndrome, cardiovascular disease, and psychological comorbidities.

A central theme of the volume is the pathophysiology of psoriasis. It explains the pivotal role of immune dysregulation, particularly the interaction between dendritic cells, T lymphocytes, and keratinocytes. The IL-23/Th17 axis is described as a major driver of chronic inflammation, with cytokines such as TNF-α, IL-17, and IL-22 playing crucial roles in keratinocyte hyperproliferation and plaque formation. By linking molecular pathways to clinical manifestations, the book provides a scientific foundation for targeted therapies.

Clinical variants of psoriasis are carefully reviewed, including plaque psoriasis (the most common form), guttate psoriasis, inverse psoriasis, pustular psoriasis, and erythrodermic psoriasis. Nail involvement and psoriatic arthritis receive dedicated attention, underscoring the need for early detection and interdisciplinary management. The text also describes validated assessment tools such as the Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI), which help guide treatment decisions and monitor therapeutic response.

Management strategies are presented in a structured and practical manner. Topical therapies remain the cornerstone of treatment for mild to moderate disease. The book discusses corticosteroids, vitamin D analogues (e.g., calcipotriol), retinoids, and combination preparations, emphasizing proper application techniques and strategies to minimize adverse effects. The importance of patient adherence and education is strongly emphasized, as consistent use of topical agents significantly improves outcomes.

For moderate to severe psoriasis, phototherapy is explored as an effective option. Narrowband UVB therapy and psoralen plus UVA (PUVA) are reviewed in detail, including indications, protocols, and potential risks. The volume provides guidance on patient selection and long-term monitoring to reduce cumulative phototoxicity.

Systemic therapies represent a major focus of the book. Traditional agents such as methotrexate, cyclosporine, and acitretin are discussed extensively, including mechanisms of action, dosing strategies, contraindications, and monitoring requirements. The authors provide practical advice for balancing efficacy with safety, particularly in patients with comorbid conditions.

One of the most significant advancements in psoriasis management is the development of biologic therapies. The book thoroughly reviews biologics targeting TNF-α (e.g., etanercept, infliximab, adalimumab), IL-12/23, IL-17, and IL-23 pathways. These agents have transformed the therapeutic landscape, offering high levels of skin clearance and improved quality of life. The text explains criteria for initiating biologic therapy, screening protocols (including tuberculosis testing), and strategies for switching treatments in cases of inadequate response.

Emerging small-molecule therapies and future directions are also explored. The authors discuss oral agents that modulate intracellular signaling pathways, reflecting the rapid evolution of precision medicine in dermatology. Special populations—including children, pregnant women, elderly patients, and those with significant comorbidities—are addressed with tailored treatment considerations.

Beyond pharmacologic interventions, the book underscores the importance of holistic care. Lifestyle modifications such as weight management, smoking cessation, and stress reduction are encouraged as adjunctive measures. The psychosocial burden of psoriasis is given considerable attention, recognizing the stigma, anxiety, and depression that often accompany visible skin disease. Multidisciplinary collaboration between dermatologists, rheumatologists, cardiologists, and mental health professionals is recommended for comprehensive management.

In summary, Management of Psoriasis (Volume 38 of Current Problems in Dermatology) offers a balanced blend of scientific insight and practical therapeutic guidance. It reflects the dramatic shift from broad immunosuppression to highly targeted biologic therapy, while maintaining attention to safety, patient-centered care, and long-term disease control. This volume serves as a valuable resource for clinicians seeking evidence-based strategies to manage psoriasis effectively and improve both clinical outcomes and quality of life for affected patients.